THIS STORY HAS BEEN APPROVED BY THE CUSTOMER FOR EXTERNAL PUBLICATION. PLEASE FEEL FREE TO SHARE!
Read it here: jmp.com/miltenyi. Watch it on YouTube here.
Accelerating cell and gene therapy with data-driven science
We’re excited to share our new customer success story from Miltenyi Biotec where JMP is helping scientists and engineers make data-driven decisions that accelerate cell and gene therapies.
Video summary
Miltenyi Biotec uses JMP to empower scientists and engineers with intuitive, visual analytics that bridge scientific intuition and statistical rigor. By enabling quality-by-design, faster analysis, and confident regulatory communication, JMP helps accelerate the delivery of life-changing therapies to patients.
Key takeaways
-
Data-driven quality is foundational.
At Miltenyi Biotec, analytics supports quality, reproducibility, and regulatory compliance across R&D, manufacturing, and process development.
-
JMP makes advanced analytics accessible and actionable.
With intuitive, no-code tools for DOE, visual modeling, and multivariate analysis, JMP empowers scientists and engineers to work proactively and apply quality by design in a practical way.
-
Better analytics accelerate therapies for patients.
By reducing analysis time and moving beyond trial-and-error experimentation, Miltenyi gains confidence in process decisions and shortens timelines for bringing cell and gene therapies to market.
Return on investment (ROI)
-
Using JMP reduced statistical analysis and control chart generation time by approximately 70% compared to manual Excel-based workflows.
-
The reduction in analysis time translated into weeks gained during process scale-up, accelerating development timelines and helping therapies move more quickly toward clinical and commercial readiness.
-
Structured DOE, quality by design, and visual analytics replaced trial-and-error experimentation, resulting in more confident, data-backed process decisions, stronger regulatory documentation, and reduced risk of costly delays.
Keywords
- Quality by design
- Cell and gene therapy
- Design of experiments
- Process development
- Regulatory compliance
